BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10415816)

  • 41. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts.
    Ottino P; He J; Axelrad TW; Bazan HE
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):487-96. PubMed ID: 15671273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cell surface activation of progelatinase A (proMMP-2) and cell migration.
    Nagase H
    Cell Res; 1998 Sep; 8(3):179-86. PubMed ID: 9791731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
    Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of gelatinase A (72-kDa type IV collagenase) induced by monensin in normal human fibroblasts.
    Li L; Akers K; Eisen AZ; Seltzer JL
    Exp Cell Res; 1997 May; 232(2):322-30. PubMed ID: 9168808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thrombin induces the activation of progelatinase A in vascular endothelial cells. Physiologic regulation of angiogenesis.
    Zucker S; Conner C; DiMassmo BI; Ende H; Drews M; Seiki M; Bahou WF
    J Biol Chem; 1995 Oct; 270(40):23730-8. PubMed ID: 7559545
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenylmercuric acetate and furin-type convertases.
    Santavicca M; Noel A; Angliker H; Stoll I; Segain JP; Anglard P; Chretien M; Seidah N; Basset P
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):953-8. PubMed ID: 8645182
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Progelatinase A activation during tumor cell invasion.
    Stetler-Stevenson WG
    Invasion Metastasis; 1994-1995; 14(1-6):259-68. PubMed ID: 7657518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells.
    Yu M; Sato H; Seiki M; Thompson EW
    Cancer Res; 1995 Aug; 55(15):3272-7. PubMed ID: 7614461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thrombin-thrombomodulin activation of protein C facilitates the activation of progelatinase A.
    Pekovich SR; Bock PE; Hoover RL
    FEBS Lett; 2001 Apr; 494(1-2):129-32. PubMed ID: 11297749
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.
    Imai K; Ohuchi E; Aoki T; Nomura H; Fujii Y; Sato H; Seiki M; Okada Y
    Cancer Res; 1996 Jun; 56(12):2707-10. PubMed ID: 8665498
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
    Fernandez-Catalan C; Bode W; Huber R; Turk D; Calvete JJ; Lichte A; Tschesche H; Maskos K
    EMBO J; 1998 Sep; 17(17):5238-48. PubMed ID: 9724659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reciprocated matrix metalloproteinase activation: a process performed by interstitial collagenase and progelatinase A.
    Crabbe T; O'Connell JP; Smith BJ; Docherty AJ
    Biochemistry; 1994 Dec; 33(48):14419-25. PubMed ID: 7981201
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts.
    Boyd RS; Balkwill FR
    Br J Cancer; 1999 May; 80(3-4):315-21. PubMed ID: 10408832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methods for studying activation of matrix metalloproteinases.
    Knäuper V; Murphy G
    Methods Mol Biol; 2001; 151():377-87. PubMed ID: 11217313
    [No Abstract]   [Full Text] [Related]  

  • 55. Matrix metalloproteinase-2 activation in human hepatic fibrosis regulation by cell-matrix interactions.
    Préaux AM; Mallat A; Nhieu JT; D'Ortho MP; Hembry RM; Mavier P
    Hepatology; 1999 Oct; 30(4):944-50. PubMed ID: 10498646
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes.
    Ward RV; Atkinson SJ; Slocombe PM; Docherty AJ; Reynolds JJ; Murphy G
    Biochim Biophys Acta; 1991 Aug; 1079(2):242-6. PubMed ID: 1911847
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase.
    Kinoshita T; Sato H; Takino T; Itoh M; Akizawa T; Seiki M
    Cancer Res; 1996 Jun; 56(11):2535-8. PubMed ID: 8653693
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional characterization of MT3-MMP in transfected MDCK cells: progelatinase A activation and tubulogenesis in 3-D collagen lattice.
    Kang T; Yi J; Yang W; Wang X; Jiang A; Pei D
    FASEB J; 2000 Dec; 14(15):2559-68. PubMed ID: 11099475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinase.
    Chen JM; Fortunato M; Stevens RA; Barrett AJ
    Biol Chem; 2001 May; 382(5):777-83. PubMed ID: 11517930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tyrosine phosphorylation mediates ConA-induced membrane type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in MDA-MB-231 human breast carcinoma cells.
    Yu M; Bowden ET; Sitlani J; Sato H; Seiki M; Mueller SC; Thompson EW
    Cancer Res; 1997 Nov; 57(22):5028-32. PubMed ID: 9371497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.